BTG, Mirada Medical secure CE Mark certification for Simplicit90Y dosimetry software

17 October 2016 (Last Updated October 17th, 2016 18:30)

BTG, a healthcare company, along with Mirada Medical Ltd, a global brand in medical imaging software, has announced CE Mark certification for Simplicit90Y dosimetry software, which is intended to optimise the planning of 90Y selective internal radiation therapy (SIRT) and facilitate personalised treatment for patients with liver cancer.

BTG, a healthcare company, along with Mirada Medical Ltd, a global brand in medical imaging software, has announced CE Mark certification for Simplicit90Y dosimetry software, which is intended to optimise the planning of 90Y selective internal radiation therapy (SIRT) and facilitate personalised treatment for patients with liver cancer.

This certification comes after approval for Simplicit90Y in Canada.

BTG and Mirada Medical together developed Simplicit90Y, which is a customised, easy-to-use, dosimetry software developed for rapid 90Y SIRT workflow.

"We designed this software to simplify the dosimetry workflow for SIRT and enhance consistency and efficiency."

Simplicit90Y™ offers digital processing, review and reporting of medical images with options for data display, quality control, image manipulation and quantification analysis.

Further, these features enable standardised and consistent dosimetry planning and post-treatment validation, and the ability to personalise treatment for each patient.

Mirada Medical managing director Matthieu Leclerc-Chalvet said: "We designed this software to simplify the dosimetry workflow for SIRT and enhance consistency and efficiency.

"Mirada Medical supports 90Y treatment quality by incorporating advanced image processing tools that facilitate the clinician's use of multi-modal images to plan 90Y SIRT treatment.

"Leveraging combined expertise from across the industry helped meet both the physician's and patient's needs and Simplicit90Y is a clear demonstration of that success."